David
Jiménez Castro
Profesor/a Titular Universidad
Duke Clinical Research Institute
Durham, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Duke Clinical Research Institute (5)
2024
-
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 83, Núm. 3, pp. 444-465
2023
-
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Thrombosis Research, Vol. 222, pp. 31-39
2022
-
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review
JAMA Cardiology, Vol. 7, Núm. 7, pp. 747-759
2017
-
Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy
Journal of the American Heart Association, Vol. 6, Núm. 7
2016
-
Extended thromboprophylaxis with betrixaban in acutely ill medical patients
New England Journal of Medicine, Vol. 375, Núm. 6, pp. 534-544